Skip to content
  • Friday, 17 April 2026
  • 10:04 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development
Pharmaceutical R&D

Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development

Teuku Ryan Apr 17, 2026 0

Obesity-focused biotechnology firm Kailera Therapeutics has successfully launched its Initial Public Offering (IPO), raising an impressive $625 million. This significant…

Read More
From list price to net price: How finance leaders decode real drug costsScience News: A Century of Empowering Public Understanding of Science, Medicine, and TechnologyTWiV 1291: A foot in the door for cytomegalovirusScience News: A Century of Empowering Public Understanding of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine ModificationLLMOps in 2026: The 10 Tools Every Team Must Have
Can the heart heal itself? New study says it canGroundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine DevelopmentEli Lilly is now pharma’s top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn’t celebratingUC Berkeley Researchers Uncover Neural Circuit Linking Deep Sleep to Growth Hormone Release and Metabolic Health
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Can the heart heal itself? New study says it can
Dwi Wanna Apr 17, 2026
Biotech & Genetic Research
Groundbreaking Nanodisc Platform Unveils Unprecedented Insights into Viral Protein-Antibody Interactions, Promising Accelerated Vaccine Development
Jia Lissa Apr 17, 2026
Laboratory Automation & Robotics
Eli Lilly is now pharma’s top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn’t celebrating
Lana Keisha Apr 17, 2026
Neuroscience & Brain Research
UC Berkeley Researchers Uncover Neural Circuit Linking Deep Sleep to Growth Hormone Release and Metabolic Health
Rifan Muazin Apr 17, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ